Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 03:03 am EST
Hanmi Pharm. Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 1,110.79 million compared to KRW 1,873 million a year ago. Net income was KRW 54,708.97 million compared to KRW 25,374.29 million a year ago. Basic earnings per share from continuing operations was KRW 4,310.7843 compared to KRW 1,998.0392 a year ago. Basic earnings per share was KRW 4,310.7843 compared to KRW 1,998.0392 a year ago.
For the nine months, sales was KRW 4,355.85 million compared to KRW 3,710.73 million a year ago. Net income was KRW 111,836.34 million compared to KRW 63,311.68 million a year ago. Basic earnings per share from continuing operations was KRW 8,811.7647 compared to KRW 4,983.3333 a year ago. Basic earnings per share was KRW 8,811.7647 compared to KRW 4,983.3333 a year ago.